Form 4: Freshpet CEO Trades Shares Under 10b5-1 Plan

Freshpet CEO William B. Cyr reported transactions involving the purchase and sale of company common stock and options under a pre-arranged Rule 10b5-1 trading plan.

Summary

• William B. Cyr, CEO of Freshpet, Inc., executed a series of transactions on May 22, 2026, involving the purchase of common stock and the sale of common stock and vested options.
• These transactions were conducted under a Rule 10b5-1 trading plan adopted on November 5, 2025, which is designed to comply with affirmative defense conditions for insider trading.
• Cyr acquired 62,369 shares of common stock at $10.23 per share, and an additional 4,620, 9,030, and 7,981 shares at the same price, with these latter acquisitions being held indirectly through his spouse, a spousal trust, and a descendants' trust.
• Simultaneously, Cyr sold a total of 43,318 shares of common stock at weighted average prices of $50.51 and $51.26, with sales occurring in multiple transactions within specified price ranges.
• He also disposed of vested options to purchase common stock, with the number of options disposed of corresponding to the shares acquired under the plan.
• Following these transactions, Cyr's direct beneficial ownership of common stock stands at 253,739 shares, with additional indirect holdings through various trusts and his spouse.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While the CEO is selling shares, it's under a pre-established compliance plan, and the acquisition of shares at a lower price suggests continued belief in the company's value.

Positives

• The transactions were executed under a Rule 10b5-1 plan, indicating adherence to established compliance procedures for insider trading.
• The CEO's acquisition of shares at $10.23 per share suggests a belief in the company's future value at that price point.
• The weighted average sale prices of $50.51 and $51.26 indicate a significant increase in share value since the options were granted or the purchase price was set.

Negatives

• The sale of a substantial number of shares (43,318) by the CEO could be interpreted negatively by the market, despite being part of a pre-planned strategy.
• The weighted average sale prices suggest that the CEO is realizing gains at a time when the stock price is considerably higher than the purchase price of newly acquired shares.

Risks

• The primary risk is market perception of the CEO selling shares, which could lead to downward pressure on the stock price, irrespective of the 10b5-1 plan's compliance.
• The weighted average sale prices indicate a range of selling prices, and any future volatility could impact the overall value realized from these transactions.

Future Outlook

The filing itself does not contain forward-looking statements or guidance. However, the execution of a Rule 10b5-1 plan implies a structured approach to managing future stock transactions based on pre-determined conditions.

Management Comments

• The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025.
• The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.98 to $50.97.
• The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.98 to $51.59.
• The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set in this Form 4.
• The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020.

Industry Context

StockSavvy.ai notes that the use of Rule 10b5-1 plans by executives is a common practice in the public markets to facilitate planned stock sales while mitigating insider trading concerns. This filing demonstrates standard corporate governance procedures for executive compensation and liquidity management.

Stakeholder Impact

• Shareholders: May react to the CEO's stock sales, potentially leading to short-term price fluctuations, though the 10b5-1 plan mitigates concerns about non-public information.
• Employees: The CEO's transactions, while compliant, could influence employee sentiment regarding the company's stock performance.
• Management: Demonstrates adherence to corporate governance standards for executive stock transactions.

Next Steps

• The reporting person may continue to execute transactions under the Rule 10b5-1 plan as per its terms.
• Full information regarding shares sold at each price within the specified ranges will be provided upon request to Freshpet, Inc., security holders, or the SEC staff.

Key Dates

Keywords

Form 4, SEC Filing, Insider Trading, Rule 10b5-1, William B. Cyr, Freshpet Inc., FRPT, Stock Options, Common Stock, Beneficial Ownership, Securities Transaction